Table 1.
Studies Assessing Clinical Presentations without control group
| Table A (studies without control group) | |||||
|---|---|---|---|---|---|
| Source | Clinical setting, Years | No. of Patients | Age, Mean (Range) | Gender (M,F) | Ref |
| Chung-Yau Lo et al., 2000 | Queen Mary hospital, Hong Kong, China, 1981–1998 | 29 (24 diagnosed in life, 4 postmortem, 1 operated with an unexpected diagnosis | Median = 50 (18–75) | 11,18 | [3] |
| M. Mannelli et al., 1999 | 18 centers from all over Italy, 1978–1997 | 258 | 44 (8–84) in female 46(12–79) in male |
– | [6] |
| Gennaro Favia et al., 1998 | A university endocrine surgery unit, Italy, 1977–1996 | 55 | 41 (10–63) | 28,27 | [7] |
| Gunnar Stenstrom et al., 1988 | A university hospital, Sweden, 1956–1982 | 64 | 45 (15–79) | 30,34 | [8] |
| J.W. Lance and Hinterberger, 1976 | A University Hospital in Sydney, Australia | 27 | 9–54 | 14,13 | [15] |
| Patócs et al., 2004 | Faculty of Medicine, Semmelweis University in Budapest, Hungary. 1995–2003 |
41 | (20–73) | 11,30 | [21] |
| FC Hernandez et al., 2000 | University Hospital “Virgen de la Arrixaca”, Murcia, Spain. 1994–1998 |
57 | 42 (7–71) | 34,23 | [22] |
| Laurence Amar et al., 2005 | Referral to a Hypertension unit, France, 1975–2003 | 192 | 44 | 89,103 | [24] |
| K.C. Loh et al. 1997 | Endocrine clinics, Nova Scotia, Canada, 1986–1995 | 18 | 42 (12–81) | 3,15 | [25] |
| Charles AG Proye et al., 1994 | 3 medical centers, France, 1951–1992 | 310 | – | – | [26] |
| P.F. Plouin et al., 1997 | A hospital in Paris, France, 1975–1994 | 129 | 42.6 (13–80) | 63,66 | [27] |
| Roger R. Perry et al., 1990 | Surgery branch of National cancer instate, Maryland, USA, 1982–1989 | 25 (extra-abdominal and 1 incidental discovery were excluded) | 39.6(16–74) | 6,19 | [28] |
| TD O'halloran et al., 2001 | St. Vincent hospital Ireland, 1950–1997 | 33 | 40.6 (12–74) | 9,24 | [29] |
| Aguilo et al., 1991 | University hospital, Puerto Rico, 1970–1990 | 24 (19 diagnosed clinically and 5 post-mortem) | 43.2 (17–74) | 14,10 | [30] |
| J.E. Thomas et al., 1966 | Mayo clinic, USA. 1945–1964 |
100 (97 in life and 3 autopsy) | 41 (4–67) | 42,58 | [31] |
| Robert Kopetschke et al., 2009 | 4 endocrine centers, Germany, 1973–2007 | 183 | 12–85 | – | [32] |
| C. Charles et al. 1984 | A university hospital, Jamaica, 1963–1983 | 16 | 38 (13–66) | 8,8 | [33] |
| Wei-ber Liao et al., 2000 | Chang Gung memorial hospital, Taiwan, 1993–1997 | 25 | 49 (16–68) | 14–11 | [34] |
| Joyce SY Yau et al. 2010 | endocrine clinics of the Kowloon West Cluster hospitals, china. 1994–2003 | 17 (19 at first. 2 lost to follow up) | 47 (17–72) | 6,11 | [35] |
| Van Duinen et al. 2010 | Leiden university medical center, Netherland, 1975–2008 | 28 patients whom the pheochromocytoma was diagnosed based on signs and symptoms | 47 | – | [36] |
| Bernard Goldny et al., 2001 | Department of General Surgery of the University of Munster Hospital, Germany. 1967–1998 | 133 | 41.4 (2–75) | 68,65 | [37] |
| I.M. Modlin et al. 1979 | A number of hospitals, England, 1955–1976 | 72 (58 diagnosed in life) | – | [38] | |
| E. J. Ross and Griffith 1989 | 3 hospitals, London, England, 1952–1982 | 54 | 12–74 | 16,38 | [39] |
| Ulf Niemann et al., 2002 | University hospital, Germany. 1974–2000 | 87 | 49 (14–78) | 38,49 | [40] |
| Takyo Noshiro et al., 2000 | Tohoku University School of Medicine, Sendai, Japan.1957–1995 |
95 (2 autopsy) | – | 43,52 | [41] |
| Richard E. Goldstein et al.,1999 | 2 medical centers, Tennessee, USA, 1950–1998 | 84 | 42 (9–79) | 38,66 | [42] |
| Khoram manes et al. 2005 | Sahlgrenska University Hospital. western region of Sweden. 1950–1997 |
121 | 47 (7–71) | 53,68 | [43] |
| N. Sharma et al., 2001 | Tertiary care hospital, Chandigarh, India, 1989–1996 | 30 | 24 (17–31) | 17, 13 | [44] |
| Masky P et al. 2012 | Tribhuvan University Teaching Hospital, Maharajgunj, Kathmandu, Nepal. 2008–2011 | 12 | 36 (12–65) | 5,7 | [45] |